1. Home
  2. HSDT vs BHST Comparison

HSDT vs BHST Comparison

Compare HSDT & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HSDT

Helius Medical Technologies Inc. (DE)

HOLD

Current Price

$2.17

Market Cap

98.2M

Sector

Health Care

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$4.61

Market Cap

97.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HSDT
BHST
Founded
N/A
2007
Country
United States
Canada
Employees
21
87
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.2M
97.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HSDT
BHST
Price
$2.17
$4.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$10.00
AVG Volume (30 Days)
363.1K
26.6K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$91.56
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$4.10
52 Week High
$25.50
$12.80

Technical Indicators

Market Signals
Indicator
HSDT
BHST
Relative Strength Index (RSI) 53.60 59.70
Support Level $1.71 $4.27
Resistance Level $2.37 $5.02
Average True Range (ATR) 0.16 0.13
MACD 0.04 0.03
Stochastic Oscillator 81.30 72.86

Price Performance

Historical Comparison
HSDT
BHST

About HSDT Helius Medical Technologies Inc. (DE)

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: